Avibactam Intermediate: A Key Component in Combating Bacterial Resistance
Exploring the synthesis and significance of CAS 1174020-25-7 for advanced antibacterial therapies.
Get a Quote & SampleProduct Core Value
Avibactam Intermediate
This essential pharmaceutical intermediate, identified by CAS No. 1174020-25-7, is critical for the synthesis of avibactam. Avibactam is a potent beta-lactamase inhibitor that plays a vital role in restoring the efficacy of antibiotics against resistant bacterial strains.
- Understanding the avibactam intermediate synthesis process is crucial for pharmaceutical manufacturers aiming to produce effective antibacterial agents.
- The CAS 1174020-25-7 properties, including its high purity exceeding 98%, make it an ideal building block for complex drug molecules.
- Sourcing high purity avibactam intermediate from reliable suppliers ensures compliance with stringent pharmaceutical quality standards.
- Avibactam beta-lactamase inhibitor intermediate is indispensable in the fight against multi-drug resistant pathogens.
Advantages Offered
Enhanced Antibacterial Efficacy
By serving as a key component in avibactam synthesis, this intermediate directly contributes to developing drugs that overcome antibiotic resistance, a critical challenge in modern medicine, aligning with goals for novel antibacterial agent development.
Assured Quality and Purity
With certifications like GMP, ISO 9001, and FDA, and a purity level greater than 98%, this pharmaceutical intermediate guarantees the quality and consistency required for drug development, supporting clinical research support.
Supports Advanced Chemical Synthesis
Its defined chemical structure and properties make it an excellent starting material for advanced chemical synthesis, facilitating the creation of complex pharmaceutical compounds for drug discovery pathways.
Key Applications
Pharmaceutical Synthesis
This intermediate is fundamental in the multi-step pharmaceutical synthesis of avibactam, a key drug in treating infections caused by resistant bacteria, thereby supporting advanced antibacterial therapies.
Combating Resistant Infections
Its application is vital for producing avibactam, which is used in combination therapies to treat severe bacterial infections, particularly those caused by Gram-negative bacteria that have developed resistance mechanisms.
Drug Discovery & Development
As a crucial building block, it supports ongoing drug discovery and development efforts aimed at creating new and more effective treatments for infectious diseases.
Research and Development
Laboratories and research institutions utilize this intermediate in R&D to explore novel therapeutic approaches and understand the mechanisms of antibiotic resistance.